Key terms

About CDNA

CareDx, Inc. operates as a transplant diagnostics company, which discovers, develops and commercializes diagnostic solutions. Its products include AlloMap, AlloSure and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest CDNA news

Mar 11 4:13pm ET CareDx Enhances Board with Financial Expert Riggsbee Mar 06 6:25am ET CareDx Hold Rating: Balancing Modest Growth Prospects with Operational Uncertainties Feb 29 12:53pm ET CareDx turns positive with CMS transplant update seen as positive Feb 29 12:33pm ET CMS announcement positive for CareDx and Natera, says Craig-Hallum Feb 29 12:30pm ET CMS says transplant patients can continue to access blood tests Feb 29 6:44am ET Balancing Growth Prospects Against Financial Challenges: A Hold Rating for CareDx Feb 28 4:49pm ET CareDx Unveils Updated Financial Health and Strategy Presentation Feb 28 4:31pm ET CareDx sees FY24 revenue $260M-$274M, consensus $260.6M Feb 28 4:30pm ET CareDx reports Q4 EPS (17c), consensus (27c) Feb 27 8:25am ET Natera announces next phase of CareDx patent infringement litigation Feb 26 9:07am ET Craig-Hallum Issues a Hold Rating on CareDx (CDNA) Jan 29 6:35am ET H.C. Wainwright Keeps Their Hold Rating on CareDx (CDNA) Jan 28 7:12am ET CareDx found to have not infringed on one Natera patent, infringed on another Jan 26 3:55pm ET Wolfe reiterates Outperform on Natera after favorable jury decision Jan 26 1:37pm ET CareDx weakness attributed to ruling in patent fight Jan 09 9:08am ET CareDx (CDNA) Gets a Hold from Craig-Hallum Jan 09 7:07am ET CareDx sees FY24 revenue $279M-$280M, consensus 276.43M Jan 07 5:30am ET BTIG Keeps Their Hold Rating on CareDx (CDNA) Jan 02 9:14am ET BTIG Sticks to Their Hold Rating for CareDx (CDNA) Dec 31 5:09am ET BTIG Keeps Their Hold Rating on CareDx (CDNA)

No recent news articles are available for CDNA

No recent press releases are available for CDNA

CDNA Financials

1-year income & revenue

Key terms

CDNA Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

CDNA Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms